Journal article
Prevalence of endoscopic improvement and remission according to patient‐reported outcomes in ulcerative colitis
Abstract
BACKGROUND: Treatment targets for ulcerative colitis are evolving towards achievement of endoscopic improvement and remission in addition to symptom resolution. It remains to be accurately quantified what proportion of patients with symptom resolution have residual endoscopic activity that might warrant treatment modification.
AIM: To quantify the prevalence of endoscopic improvement and remission amongst ulcerative colitis patients with …
Authors
Dulai PS; Singh S; Jairath V; Ma C; Narula N; Casteele NV; Peyrin‐Biroulet L; Vermeire S; D’Haens G; Feagan BG
Journal
Alimentary Pharmacology & Therapeutics, Vol. 51, No. 4, pp. 435–445
Publisher
Wiley
Publication Date
2 2020
DOI
10.1111/apt.15577
ISSN
0269-2813
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdultAgedAntibodies, Monoclonal, HumanizedClinical Trials as TopicCohort StudiesColitis, UlcerativeEndoscopy, GastrointestinalFemaleGastrointestinal AgentsGastrointestinal HemorrhageHumansInduction ChemotherapyInfliximabMaintenance ChemotherapyMaleMiddle AgedPatient Reported Outcome MeasuresPiperidinesPrevalencePyrimidinesPyrrolesRemission InductionYoung Adult